[November 27, 2015]

Research and Markets: Global Tetanus Pipeline Review, H2 2015

Research and Markets (http://www.researchandmarkets.com/research/45652m/tetanus) has announced the addition of the "Tetanus - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Tetanus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tetanus and special featurs on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Mentioned

• Beijing Minhai Biotechnology Co., Ltd.
• Bharat Biotech International Limited
• Biological E. Limited
• Boryung Pharmaceutical Co., Ltd.
• Daiichi Sankyo Company, Limited
• GlaxoSmithKline Plc
• Green Cross Corporation
• Indian Immunologicals Limited
• LG Life Sciences, Ltd.
• Panacea Biotec Limited
• Prometheon Pharma, LLC
• Sanofi
• Sanofi Pasteur SA
• Serum Institute of India Limited
• Sinovac Biotech Ltd.
• Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/45652m/tetanus.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005377/en/

[ Back To TMCnet.com's Homepage ]